Rare diseases
Investigational molecules
Locations
296 conditions with trials, the busiest first
580 trials across Europe, recruiting first
Study on the Safety and Effects of ARO-C3 for Adults with Complement-Mediated Kidney Disease
GermanyStudy on Ilofotase Alfa to Prevent Kidney Damage in Patients Undergoing Open Heart Surgery
BelgiumStudy Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer
BulgariaStudy of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment
Belgium
FranceStudy on Pre-Operative Nivolumab and Relatlimab for Adults with Stage II-IIIa Muscle-Invasive Bladder Cancer
The NetherlandsStudy on the Effectiveness and Safety of SYNB1934 for Adults with Phenylketonuria (PKU)
DenmarkStudy of Pembrolizumab, Favezelimab, and Lenvatinib for Patients with Renal Cell Carcinoma
FranceStudy Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer
AustriaStudy on Sibeprenlimab for Patients with IgA Nephropathy
BelgiumStudy of BGB-A425, LBL-007, and Tislelizumab for Patients with Advanced Head and Neck Cancer, Lung Cancer, or Kidney Cancer
FranceStudy on the Effectiveness and Safety of MC2-25 Cream for Itching in Chronic Kidney Disease Patients
GermanyThe therapies tested most often in Renal and urinary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
